Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme
Open Access
- 6 April 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 165 (1), 1-7
- https://doi.org/10.1111/j.1365-2249.2011.04384.x
Abstract
Common variable immunodeficiency disorders (CVIDs) are the most frequent symptomatic primary immunodeficiencies in adults. They comprise a heterogeneous group of pathologies, with frequent non‐infectious complications in addition to the bacterial infections that usually characterize their presentation. Complications include a high risk of malignancy, especially lymphoma and gastric cancer. Helicobacter pylori infection and pernicious anaemia are risk predictors for gastric cancer in the general population and probably in patients with CVIDs. Screening for gastric cancer in a high‐risk population appears to improve survival. Given the increased risk of gastric cancer in patients with CVIDs and prompted by a case of advanced gastric malignancy in a patient with a CVID and concomitant pernicious anaemia, we performed a review of the literature for gastric cancer and conducted a cohort study of gastric pathology in 116 patients with CVIDs under long‐term follow‐up in Oxford. Regardless of the presence of pernicious anaemia or H. pylori infection, patients with CVIDs have a 10‐fold increased risk of gastric cancer and are therefore a high‐risk population. Although endoscopic screening of all patients with CVIDs could be considered, a more selective approach is appropriate and we propose a surveillance protocol that should reduce modifiable risk factors such as H. pylori, in order to improve the management of patients with CVIDs at risk of gastric malignancy.Keywords
This publication has 55 references indexed in Scilit:
- Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulationClinical and Experimental Immunology, 2009
- Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsBritish Journal of Haematology, 2009
- Accuracy of Diagnostic Tests forHelicobacter pylori:A ReappraisalClinical Infectious Diseases, 2009
- Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiencyClinical and Experimental Immunology, 2009
- Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemiaClinical and Experimental Immunology, 2009
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Long term follow up of patients treated for Helicobacter pylori infectionGut, 2005
- A follow up model for patients with atrophic chronic gastritis and intestinal metaplasiaJournal of Clinical Pathology, 2004
- Working group report on schistosomes, liver flukes and Helicobacter pylori. Meeting held at IARC, LYON, 7–14 june 1994International Journal of Cancer, 1995
- HYPOGAMMAGLOBULINAEMIA AND GASTRIC CANCERThe Lancet, 1985